Classification of Non-Hodgkin's Lymphoma

Hematology/Oncology Clinics of North America

Volumn 22, Issue 5, 2008, Pages 781-805

  Good, David J ^a   Gascoyne, Randy D ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Classification; Cytogenetics; Immunophenotype; Lymphoma; Molecular genetics; Pathology

Indexed keywords

ANAPLASTIC LARGE CELL LYMPHOMA; ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; B CELL LYMPHOBLASTIC LYMPHOMA; B CELL LYMPHOMA; B LYMPHOCYTE; BURKITT LYMPHOMA; CANCER DIAGNOSIS; CELL LINEAGE; CHROMOSOME ANALYSIS; CHRONIC LYMPHATIC LEUKEMIA; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; ENTEROPATHY; FOLLLICULAR LYMPHOMA; HEPATOSPLENIC T CELL LYMPHOMA; HISTOPATHOLOGIC SKIN REACTION; HUMAN; IMMUNOPHENOTYPING; LYMPHOPLASMACYTIC LYMPHOMA; MANTLE CELL LYMPHOMA; MOLECULAR GENETICS; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NATURAL KILLER CELL; NATURAL KILLER CELL LEUKEMIA; NONHODGKIN LYMPHOMA; PERIPHERAL T CELL LYMPHOMA; PRIMARY CUTANEOUS CD30 POSITIVE T CELL LYMPHOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; REVIEW; SEZARY SYNDROME; SMALL LYMPHOCYTIC LYMPHOMA; SPLENIC MARGINAL ZONE LYMPHOMA; SUBCUTANEOUS PANNICULITIS LIKE T CELL LYMPHOMA; T CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA; T CELL LEUKEMIA; T CELL LYMPHOMA; T LYMPHOCYTE;

B-LYMPHOCYTES; DIAGNOSIS, DIFFERENTIAL; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, NON-HODGKIN; T-LYMPHOCYTES;

EID: 54049106973     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2008.07.008     Document Type: Review

References (97)

1. Hicks E.B., Rappaport H., and Winter W.J. Follicular lymphoma: a re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases. Cancer 9 4 (1956) 792-821
2. Lukes R.J., and Collins R.D. Immunologic characterization of human malignant lymphomas. Cancer 34 S8 (1974) 1488-1503
3. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 49 10 (1982) 2112-2135
4. Lennert K., Stein H., and Kaiserling E. Cytological and functional criteria for the classification of malignant lymphomata. Br J Cancer 31 S2 (1975) 29-43
5. Kim H., Zelman R.J., Fox M.A., et al. Pathology Panel for Lymphoma Clinical Studies: a comprehensive analysis of cases accumulated since its inception. J Natl Cancer Inst 68 1 (1982) 43-67
6. Whitcomb C.C., Crissman J.D., Flint A., et al. Reproducibility in morphologic classification of non-Hodgkin's lymphomas using the Lukes-Collins system. The Southeastern Cancer Study Group experience. Am J Clin Pathol 82 4 (1984) 383-388
7. NCI non-Hodgkin's Classification Project Writing Committee. Classification of non-Hodgkin's lymphomas. Reproducibility of major classification systems. Cancer 55 1 (1985) 91-95
8. Dick F., VanLier S., Banks P., et al. Use of the working formulation for non-Hodgkin's lymphoma in epidemiologic studies: agreement between reported diagnoses and a panel of experienced pathologists. J Natl Cancer Inst 78 6 (1987) 1137-1144
9. Harris N.L., Jaffe E.S., Stein H., et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84 5 (1994) 1361-1392
10. Anon. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 89 11 (1997) 3909-3918
11. In: Jaffe E.S., Harris N.L., and Stein H. (Eds). World Health Organization classification of tumors. Tumors of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon (France)
12. Ozdemirli M., Fanburg-Smith J.C., Hartmann D.P., et al. Differentiating lymphoblastic lymphoma and Ewing's sarcoma: lymphocyte markers and gene rearrangement. Mod Pathol. 14 11 (2001) 1175-1182
13. de Jong D. Molecular classification of follicular lymphoma: a cross talk of genetic and immunologic factors. J Clin Oncol 23 26 (2005) 6358-6363
14. Dogan A., Bagdi E., Munson P., et al. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas. Am J Surg Pathol 24 6 (2000) 846-852
15. Dogan A., Du M.Q., Aiello A., et al. Follicular lymphomas contain a clonally linked but phenotypically distinct neoplastic B-cell population in the interfollicular zone. Blood 91 12 (1998) 4708-4714
16. Mann R.B., and Berard C.W. Criteria for the cytologic subclassification of follicular lymphomas: a proposed alternative method. Hematol Oncol 1 2 (1983) 187-192
17. Metter G.E., Nathwani B.N., Burke J.S., et al. Morphological subclassification of follicular lymphoma: variability of diagnoses among hematopathologists, a collaborative study between the Repository Center and Pathology Panel for Lymphoma Clinical Studies. J Clin Oncol 3 1 (1985) 25-38
18. Nathwani B.N., Metter G.E., Miller T.P., et al. What should be the morphologic criteria for the subdivision of follicular lymphomas?. Blood 68 4 (1986) 837-845
19. Nathwani B.N., Harris N.L., Weisenburger D.D., et al. Follicular lymphoma. In: Jaffe E.S., Harris N.L., Stein H., et al. (Eds). World Health Organisation classification of tumors. Tumors of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon (France) 162-167
20. Hans C.P., Weisenburger D.D., Vose J.M., et al. A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival. Blood 101 6 (2003) 2363-2367
21. Tilly H., Rossi A., Stamatoullas A., et al. Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood 84 4 (1994) 1043-1049
22. Horsman D.E., Gascoyne R.D., Coupland R.W., et al. Comparison of cytogenetic analysis, southern analysis, and polymerase chain reaction for the detection of t(14; 18) in follicular lymphoma. Am J Clin Pathol 103 4 (1995) 472-478
23. Bakhshi A., Jensen J.P., Goldman P., et al. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 41 3 (1985) 899-906
24. Lai R., Arber D.A., Chang K.L., et al. Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia. Mod Pathol 11 9 (1998) 864-869
25. Swerdlow S.H., Berger F., Isaacson P.G., et al. Mantle cell lymphoma. In: Jaffe E.S., Harris N.L., Stein H., et al. (Eds). World Health Organisation classification of tumors. Tumors of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon (France) 168-170
26. Argatoff L.H., Connors J.M., Klasa R.J., et al. Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood 89 6 (1997) 2067-2078
27. Bosch F., Lopez-Guillermo A., Campo E., et al. Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors. Cancer 82 3 (1998) 567-575
28. Rosenberg C.L., Wong E., Petty E.M., et al. PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci U S A 88 21 (1991) 9638-9642
29. Braylan R.C., Jaffe E.S., Burbach J.W., et al. Similarities of surface characteristics of neoplastic well-differentiated lymphocytes from solid tissues and from peripheral blood. Cancer Res 36 5 (1976) 1619-1625
30. Batata A., and Shen B. Relationship between chronic lymphocytic leukemia and small lymphocytic lymphoma. A comparative study of membrane phenotypes in 270 cases. Cancer 70 3 (1992) 625-632
31. Ben-Ezra J., Burke J.S., Swartz W.G., et al. Small lymphocytic lymphoma: a clinicopathologic analysis of 268 cases. Blood 73 2 (1989) 579-587
32. Rozman C., Montserrat E., and Vinolas N. Serum immunoglobulins in B-chronic lymphocytic leukemia. Natural history and prognostic significance. Cancer 61 2 (1988) 279-283
33. Xu H.J., and Roberts-Thomson P.J. Low molecular weight IgM in the sera of patients with chronic lymphocytic leukemia. Pathology 25 1 (1993) 52-56
34. Yin C.C., Lin P., Carney D.A., et al. Chronic lymphocytic leukemia/ small lymphocytic lymphoma associated with IgM paraprotein. Am J Clin Pathol 123 4 (2005) 594-602
35. Mollejo M., Camacho F.I., Algara P., et al. Nodal and splenic marginal zone B cell lymphomas. Hematol Oncol 23 3-4 (2005) 108-118
36. Mollejo M., Algara P., Mateo M.S., et al. Splenic small B-cell lymphoma with predominant red pulp involvement: a diffuse variant of splenic marginal zone lymphoma?. Histopathology 40 1 (2002) 22-30
37. Isaacson P.G., Matutes E., Burke M., et al. The histopathology of splenic lymphoma with villous lymphocytes. Blood 84 11 (1994) 3828-3834
38. Traverse-Glehen A., Baseggio L., Callet-Bauchu E., et al. Splenic red pulp lymphoma with numerous basophilic lymphocytes: a distinct clinicopathologic and molecular entity?. Blood 111 4 (2008) 2253-2260
39. Maes B., and De Wolf-Peeters C. Marginal zone cell lymphoma-an update on recent advances. Histopathology 40 2 (2002) 117-126
40. Campo E., Miquel R., Krenacs L., et al. Primary nodal marginal zone lymphomas of splenic and MALT type. Am J Surg Pathol 23 1 (1999) 59-68
41. Camacho F.I., Algara P., Mollejo M., et al. Nodal marginal zone lymphoma: a heterogeneous tumor: a comprehensive analysis of a series of 27 cases. Am J Surg Pathol 27 6 (2003) 762-771
42. Lin P., and Medeiros L.J. Lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia: an evolving concept. Adv Anat Pathol 12 5 (2005) 246-255
43. Remstein E.D., Hanson C.A., Kyle R.A., et al. Despite apparent morphologic and immunophenotypic heterogeneity, Waldenstrom's macroglobulinemia is consistently composed of cells along a morphologic continuum of small lymphocytes, plasmacytoid lymphocytes, and plasma cells. Semin Oncol 30 2 (2003) 182-186
44. De Paepe P., and De Wolf-Peeters C. Diffuse large B cell lymphoma: a heterogeneous group of non-Hodgkin lymphomas comprising several distinct and clinicopathological entities. Leukemia 21 1 (2007) 37-43
45. Pileri S.A., Dirnhofer A., Went P., et al. Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification. Histopathology 41 6 (2002) 482-509
46. Gatter K.C., and Warnke R.A. Diffuse large B cell lymphoma. In: Jaffe E.S., Harris N.L., Stein H., et al. (Eds). World Health Organisation classification of tumors. Tumors of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon (France) 171-174
47. Delecluse H.J., Anagnostopoulos I., Dallenbach F., et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 89 4 (1997) 1413-1420
48. Colomo L., Loong F., Rives S., et al. Diffuse large B cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 28 6 (2004) 736-747
49. McCluggage W.G., Catherwood M., Alexander H.D., et al. Immunohistochemical expression of CD10 and t(14;18) chromosomal translocation may be indicators of follicle center cell origin in nodal diffuse large B-cell lymphoma. Histopathology 41 5 (2002) 414-420
50. Pittaluga S., Ayoubi T.A., Wlodarska I., et al. BCL-6 expression in reactive lymphoid tissue and in B-cell non-Hodgkin's lymphomas. J Pathol 179 2 (1996) 145-150
51. Skinnider B.F., Horsman D.E., Dupuis B., et al. Bcl-6 and Bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: correlation with 3q27 and 18q21 chromosomal abnormalities. Hum Pathol 30 7 (1999) 803-808
52. Gascoyne R.D., Adomat S.A., Krajewski S., et al. Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. Blood 90 1 (1997) 244-251
53. Matolcsy A., Inghirami G., and Knowles D.M. Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma). Blood 83 5 (1994) 1363-1372
54. Diebold J. Burkitt lymphoma. In: Jaffe E.S., Harris N.L., Stein H., et al. (Eds). World Health Organisation classification of tumors. Tumors of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon (France) 181-184
55. McClure R.F., Remstein E.D., Macon W.R., et al. Adult B-cell lymphomas with Burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior. Am J Surg Pathol 29 12 (2005) 1652-1660
56. Brunning R.D., Borowitz M., Matutes E., et al. Precursor T lymphoblastic leukemia/lymphoblastic lymphoma. In: Jaffe E.S., Harris N.L., Stein H., et al. (Eds). World Health Organisation classification of tumors. Tumors of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon (France) 115-117
57. Catovsky D., Ralfkiaer E., and Muller-Hermelink H.K. T-cell prolymphocytic leukemia. In: Jaffe E.S., Harris N.L., Stein H., et al. (Eds). World Health Organisation classification of tumors. Tumors of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon (France) 195-196
58. Valbuena J.R., Herling M., Admirand J.H., et al. T-cell prolymphocytic leukemia involving extramedullary sites. Am J Clin Pathol 123 3 (2005) 456-464
59. Chan W.C., Catovsky D., Foucar K., et al. T-cell large granular lymphocyte leukemia. In: Jaffe E.S., Harris N.L., Stein H., et al. (Eds). World Health Organisation classification of tumors. Tumors of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon (France) 197-198
60. Morice W.G., Kurtin P.J., Tefferi A., et al. Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B. Blood 99 1 (2002) 268-274
61. Lundell R., Hartung L., Hill S., et al. T-cell large granular lymphocyte leukemias have multiple phenotypic abnormalities involving pan-T-cell antigens and receptors for MHC molecules. Am J Clin Pathol 124 6 (2005) 937-946
62. Chan W.C., Wong K.F., Jaffe E.S., et al. Aggressive NK-cell leukemia. In: Jaffe E.S., Harris N.L., Stein H., et al. (Eds). World Health Organisation classification of tumors. Tumors of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon (France) 197-198
63. Shimoyama M. Diagnostic criteria and clinical subtypes of ATLL. A report from the Lymphoma Study Group (1984-87). Br J Haematol 79 3 (1991) 428-437
64. Ohshima K., Suzumiya J., Sato K., et al. Nodal T-cell lymphoma in an HTLV-1 endemic area: proviral HTLV-1 DNA, histological classification and clinical evaluation. Br J Haematol 101 4 (1998) 703-711
65. Massone C., Kodama K., Kerl H., et al. Histopathologic features of early (patch) lesions of mycosis fungoides: a morphologic study on 745 biopsy specimens from 427 patients. Am J Surg Pathol 29 4 (2005) 550-560
66. Naraghi Z.S., Seirafi H., Valikhani M., et al. Assessment of histologic criteria in the diagnosis of mycosis fungoides. Int J Dermatol 42 1 (2003) 45-52
67. Wallace M.L., and Smoller B.R. Immunohistochemistry in diagnostic dermatopathology. J Am Acad Dermatol 34 2 Pt 1 (1996) 163-186
68. Lu D., Patel K.A., Duvic M., et al. Clinical and pathological spectrum of CD8-positive cutaneous T-cell lymphomas. J Cutan Pathol 29 8 (2002) 465-472
69. Ralfkiaer E., and Jaffe E.S. Mycosis fungoides and Sézary syndrome. In: Jaffe E.S., Harris N.L., Stein H., et al. (Eds). World Health Organisation classification of tumors. Tumors of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon (France) 216-220
70. Diwan A.H., Prieto V.G., Herling M., et al. Primary Sézary syndrome commonly shows low-grade cytologic atypia and an absence of epidermotropism. Am J Clin Pathol 123 4 (2005) 510-515
71. Ralfkiaer E., Delsol G., Willemze R., et al. Primary cutaneous CD30-positive T cell lymphoproliferative disorders. In: Jaffe E.S., Harris N.L., Stein H., et al. (Eds). World Health Organisation classification of tumors. Tumors of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon (France) 221-224
72. Macgrogan G., Vergier B., Dubus P., et al. CD30-positive cutaneous large cell lymphomas: a comparative study of clinicopathologic and molecular features of 16 cases. Am J Clin Pathol 105 4 (1996) 440-450
73. El Shabrawi-Caelen L., Kerl H., and Cerroni L. Lymphomatoid papulosis: reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C. Arch Dermatol. 140 4 (2004) 441-447
74. Boulland M.L., Wechsler J., Bagot M., et al. Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins. Histopathology 36 2 (2000) 136-144
75. Chan J.K., Jaffe E.S., and Ralfkiaer E. Extranodal NK/T cell lymphoma, nasal type. In: Jaffe E.S., Harris N.L., Stein H., et al. (Eds). World Health Organisation classification of tumors. Tumors of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon (France) 204-207
76. Jaffe E.S., Chan J.K., Su I.J., et al. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas: definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 20 1 (1996) 103-111
77. Isaacson P., Wright D., Ralfkiaer E., et al. Enteropathy-type T cell lymphoma. In: Jaffe E.S., Harris N.L., Stein H., et al. (Eds). World Health Organisation classification of tumors. Tumors of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon (France) 208-209
78. Chott A., Haedicke W., Mosberger I., et al. Most CD56+ intestinal lymphomas are CD8+CD5- T-cell lymphomas of monomorphic small to medium size histology. Am J Pathol 153 5 (1998) 1483-1490
79. deLeeuw R., Zettl A., Klinker E., et al. Whole genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals two distinct lymphoma subtypes. Gastroenterology 132 5 (2007) 1902-1911
80. Jaffe E.S., and Ralfkiaer E. Hepatosplenic T-cell lymphoma. In: Jaffe E.S., Harris N.L., Stein H., et al. (Eds). World Health Organization classification of tumors. Tumors of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon (France) 210-211
81. Cooke C.B., Krenacs L., Stetler-Stevenson M., et al. Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin. Blood 88 11 (1996) 4265-4274
82. Vega F., Medeiros L.J., and Gaulard P. Hepatosplenic and other gammadelta T-cell lymphomas. Am J Clin Pathol 127 6 (2007) 869-880
83. Gonzalez C.L., Medeiros L.J., Braziel R.M., et al. T-cell lymphoma involving subcutaneous tissue: a clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol 15 1 (1991) 17-27
84. Jaffe E.S., and Ralfkiaer E. Subcutaneous panniculitis-like T cell lymphoma. In: Jaffe E.S., Harris N.L., Stein H., et al. (Eds). World Health Organisation classification of tumors. Tumors of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon (France) 212-213
85. Sen F., Rassidakis G.Z., Jones D., et al. Apoptosis and proliferation in subcutaneous panniculitis-like T-cell lymphoma. Mod Pathol 15 6 (2002) 625-631
86. Salhany K.E., Macon W.R., Choi J.K., et al. Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes. Am J Surg Pathol 22 7 (1998) 881-893
87. Willemze R., Jansen P.M., Cerroni L., et al. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group study of 83 cases. Blood 111 2 (2008) 838-845
88. Jaffe E.S., and Ralfkiaer E. Angioimmunoblastic T-cell lymphoma. In: Jaffe E.S., Harris N.L., Stein H., et al. (Eds). World Health Organisation classification of tumors. Tumors of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon (France) 225-226
89. Frizzera G., Moran E.M., and Rappaport H. Angio-immunoblastic lymphadenopathy: diagnosis and clinical course. Am J Med 59 6 (1975) 803-818
90. Anagnostopoulos I., Hummel M., Finn T., et al. Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood 80 7 (1992) 1804-1812
91. Ralfkiaer E., Muller-Hermelink H.K., and Jaffe E.S. Peripheral T-cell lymphoma, unspecified. In: Jaffe E.S., Harris N.L., Stein H., et al. (Eds). World Health Organisation classification of tumors. Tumors of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon (France) 227-229
92. Chott A., Augustin I., Wrba F., et al. Peripheral T-cell lymphomas: a clinicopathologic study of 75 cases. Hum Pathol 21 11 (1990) 1117-1125
93. Takagi N., Nakamura S., Ueda R., et al. A phenotypic and genotypic study of three node-based, low-grade peripheral T-cell lymphomas: angioimmunoblastic lymphoma, T-zone lymphoma, and lymphoepithelioid lymphoma. Cancer 69 10 (1992) 2571-2582
94. Delsol G., Ralfkiaer E., Stein H., et al. Anaplastic large cell lymphoma. In: Jaffe E.S., Harris N.L., Stein H., et al. (Eds). World Health Organisation classification of tumors. Tumors of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon (France) 230-235
95. Stein H., Foss H.D., Durkop H., et al. CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 96 12 (2000) 3681-3695
96. Falini B. Anaplastic large cell lymphoma: pathological, molecular and clinical features. Br J Haematol 114 4 (2001) 741-760
97. Nelson M., Horsman D.E., Weisenburger D.D., et al. Cytogenetic abnormalities and clinical correlations in peripheral T cell lymphoma. Br J Haematol 141 4 (2008) 461-469